Positivity in serum MMP-3 after clinical remission or low disease activity at 52 weeks leads to future joint destruction in patients with rheumatoid arthritis

Hiroe Konishi, Mai Morimoto, Kosaku Murakami, Hideo Onizawa, Akira Onishi, Takayuki Fujii, Koichi Murata, Masao Tanaka, Akio Morinobu, Masayoshi Nakano, Masahiro Koshiba
doi: https://doi.org/10.1101/2024.04.14.24305643

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Back to top
Posted April 21, 2024.
Download PDF
Data/Code
Email
Positivity in serum MMP-3 after clinical remission or low disease activity at 52 weeks leads to future joint destruction in patients with rheumatoid arthritis
Hiroe Konishi, Mai Morimoto, Kosaku Murakami, Hideo Onizawa, Akira Onishi, Takayuki Fujii, Koichi Murata, Masao Tanaka, Akio Morinobu, Masayoshi Nakano, Masahiro Koshiba
medRxiv 2024.04.14.24305643; doi: https://doi.org/10.1101/2024.04.14.24305643
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area